| 0 (0%) | 10-24 15:01 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 24.89 |
1-year : | 30.91 |
| Resists | First : | 21.31 |
Second : | 26.46 |
| Pivot price | 14.98 |
|||
| Supports | First : | 12.97 |
Second : | 10.79 |
| MAs | MA(5) : | 15.43 |
MA(20) : | 15.58  |
| MA(100) : | 13.3 |
MA(250) : | 13.34 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 65.5 |
D(3) : | 49.3 |
| RSI | RSI(14): 58.4 |
|||
| 52-week | High : | 27.5 | Low : | 4.8 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ MBX ] has closed below upper band by 9.2%. Bollinger Bands are 27.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 16.5 - 16.58 | 16.58 - 16.65 |
| Low: | 14.43 - 14.51 | 14.51 - 14.59 |
| Close: | 15.98 - 16.12 | 16.12 - 16.25 |
Fri, 24 Oct 2025
The VW Brand Producing The Coolest Concepts Isn't Porsche - CarBuzz
Fri, 24 Oct 2025
Skoda has recreated the 1000 MBX for our modern day world - Top Gear
Fri, 24 Oct 2025
Predicting MBX Biosciences Inc. trend using moving averages - 2025 Buyback Activity & Target Return Focused Picks - newser.com
Fri, 24 Oct 2025
This Rare Skoda Goes Back to the Future - Motor1.com
Fri, 24 Oct 2025
MBX Biosciences, Inc. (MBX) Stock Analysis: A Biotech With A Potential 265% Upside - DirectorsTalk Interviews
Fri, 24 Oct 2025
Stocks Flashing Renewed Technical Strength: MBX Biosciences - Investor's Business Daily
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 45 (M) |
| Shares Float | 22 (M) |
| Held by Insiders | 2.3 (%) |
| Held by Institutions | 86.5 (%) |
| Shares Short | 3,900 (K) |
| Shares Short P.Month | 3,840 (K) |
| EPS | -6.24 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.53 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -36.8 % |
| Return on Equity (ttm) | -56.3 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -1.93 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -71 (M) |
| Levered Free Cash Flow | -45 (M) |
| PE Ratio | -2.68 |
| PEG Ratio | 0 |
| Price to Book value | 2.56 |
| Price to Sales | 0 |
| Price to Cash Flow | -10.56 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|